Webinar w/ Med Learning Group | The Implementation of Anti-Amyloid Therapeutics for Alzheimer’s Disease

Thursday, June 12, 2025
7:00 p.m. to 8:00 p.m.
Virtual

REGISTER NOW

Attendees, please take this short pre-test before the scheduled webinar. – PRE-TEST LINK

PROGRAM OVERVIEW

This educational initiative is designed for pharmacists in the United States and globally who are involved in the care of patients with early symptomatic Alzheimer’s disease (MCI due to AD, or mild dementia due to AD). It uses a multi-component platform – the DETECT Initiative – to increase learner ability to review evolving clinical data informing the use of anti-amyloid therapeutics (ATTs) in the care of patients with AD, including mechanisms, efficacy, safety, and dosing and administration best practices; apply best practices for individualized patient counseling to ensure adequate monitoring and management in the provision of ATTs; design guideline-informed evidence-based protocols for preparation, dosing, and scheduling of ATTs in the clinical settings; and facilitate the management of financial and reimbursement issues for patients receiving ATTs.

TARGET AUDIENCE

The intended audience includes pharmacists in the United States and globally involved in the care of patients with early symptomatic Alzheimer’s disease (MCI due to AD, or mild dementia due to AD).

LEARNING OBJECTIVES

Upon the completion of this program, attendees should be able to:

• Review evolving clinical data informing the use of anti-amyloid therapeutics (ATTs) in the care of patients with AD, including mechanisms, efficacy, safety, and dosing and administration best practices
• Apply best practices for individualized patient counseling to ensure adequate monitoring and management in the provision of ATTs
• Design guideline-informed evidence-based protocols for preparation, dosing, and scheduling of ATTs in the clinical settings
• Facilitate the management of financial and reimbursement issues for patients receiving ATTs

VIEW EVENT BROCHURE

Speakers: 

Brad Dickerson, MD, MMSc, FAAN, FANPA
Boston, MA

Registration Rates:

VPhA Members: FREE
Non-Members: FREE

Registration will remain open until the beginning of the Webinar.

The Zoom link will be sent out automatically following online registration.

JOINT ACCREDITATION STATEMENT

In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Pharmacists and Pharmacy Technicians (ACPE) Credit Designation

Med Learning Group designates this activity for a maximum of 1.0 knowledge-based CPE contact hour.

NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.